Publications by authors named "Remi Monnier"

Claim this Profile
C
Cost-effectiveness of alectinib compared to crizotinib for the treatment of first-line ALK+ advanced non-small-cell lung cancer in France.
Marine Sivignon, Rémi Monnier, Bertrand Tehard, Stéphane Roze

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis